Kerendia 20mg Tab
Marketer
Bayer Zydus Pharma Pvt Ltd
Composition
Finerenone (20mg)
About Kerendia 20mg Tab
Kerendia 20mg Tab (Finerenone) is a medication used to treat chronic kidney disease in adults with type 2 diabetes and high albuminuria, and to reduce cardiovascular risk in this population. It works by blocking the effects of aldosterone, a hormone that can contribute to kidney damage. Common side effects include hyperkalemia, hypotension, and gastrointestinal issues. It is crucial to inform your doctor about any pre-existing medical conditions, particularly kidney or liver disease, and any medications you are taking before starting finerenone. Regular monitoring of blood potassium levels and blood pressure is typically required. Always follow your doctor's instructions regarding dosage and administration.
Last Updated On 19 Jun. 2025 | 08:02 PM (IST)
Report Error
Was this Product Information helpful?
Some people found this information helpful
User Feedback
Disclaimer
We, at MedCart make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed
medicine-related information to our consumers. However, it should, by no means, be considered a
substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship.
In fact, we detest any form of self-medication without expert advice. The sole purpose of the
information on our portal is to educate our consumers, which helps improve the communication
between a doctor and a patient. The information by no means is complete in its entirety and
should not be used to diagnose or treat any medical condition. No amount of information can
replace the experience and expertise of a doctor, therefore his/her advice always holds
priority and should be followed appropriately.

5k+ people saw this product recently
MRP
₹1,365.00
10% off applied
In Stock
₹1,228.50
(₹87.75 per unit)
For 14 Tablet (s)
Inclusive of all Taxes
Delivery Pincode
Check
Delivery in 60-90 mins
Cash on Delivery Available
Easy 7 Days Return Available
Expires on or after Dec 2024
Country of Origin: India
User Feedback